Federal Prosecutors Are Watching Rx Firms’ Handling Of Patient Info
This article was originally published in The Pink Sheet Daily
Executive Summary
Federal prosecutors are likely to bring suits against pharmaceutical manufacturers alleging violations of patient privacy provisions under the Health Insurance Portability & Accountability Act, Assistant U.S. Attorney Michael Loucks said June 22 at an IIR conference in Boston
You may also be interested in...
Trileptal Off-Label Promotion Subject Of Philadelphia U.S. Attorney Subpoena
Anti-epileptic understood to be subject of civil and criminal investigation into Novartis’ marketing practices. Trileptal subpoena is pursuant to HIPAA privacy provisions of 2003, company says.
Natrecor Use Should Be Limited, Independent Panel Convened By J&J Says
The cardiologist panel calls for use of the congestive heart failure therapy to be "strictly limited" to patients that present with symptoms in the hospital setting. The expert panel also recommends that Scios "immediately undertake" a professional educational campaign about Natrecor's appropriate uses.